Published in J Virol on December 01, 1990
Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol (1992) 2.88
Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J Virol (1992) 1.36
Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol Mol Biol Rev (2013) 1.22
Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J Virol (2012) 1.22
MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J Virol (2000) 1.14
Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol (2016) 0.81
Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction. Viruses (2016) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Recognition of cap structure in splicing in vitro of mRNA precursors. Cell (1984) 8.67
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol (1981) 6.46
Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A (1981) 5.10
Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell (1986) 4.92
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell (1983) 3.93
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol (1990) 3.44
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci U S A (1983) 3.17
Structure of the ribonucleoprotein of influenza virus. J Virol (1972) 3.11
Host gene influences sensitivity to interferon action selectively for influenza virus. Nature (1980) 2.88
Cap-dependent RNA splicing in a HeLa nuclear extract. Proc Natl Acad Sci U S A (1985) 2.82
Poly(A) site cleavage in a HeLa nuclear extract is dependent on downstream sequences. Cell (1985) 2.72
Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol (1981) 2.68
Inborn resistance of ice to orthomyxoviruses. Curr Top Microbiol Immunol (1981) 2.41
Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol (1985) 2.38
Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses. Virology (1985) 2.26
Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol (1987) 2.21
Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. Interferon (1987) 1.99
A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J Virol (1988) 1.90
Processing and nucleo-cytoplasmic transport of histone gene transcripts. Nucleic Acids Res (1984) 1.80
Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol Cell Biol (1985) 1.70
Transport of the murine Mx protein into the nucleus is dependent on a basic carboxy-terminal sequence. J Interferon Res (1987) 1.62
Monoclonal antibodies to the influenza A virus nucleoprotein affecting RNA transcription. J Virol (1981) 1.52
Identification of nuclear cap specific proteins in HeLa cells. Nucleic Acids Res (1987) 1.50
IFN-alpha induced human 78 kD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-gamma. J Interferon Res (1987) 1.42
Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J (1988) 1.32
Efficient transcription, not translation, is dependent on adenovirus tripartite leader sequences at late times of infection. J Virol (1988) 1.15
The action of recombinant bovine interferons on influenza virus replication correlates with the induction of two Mx-related proteins in bovine cells. Virology (1988) 1.12
High-level expression in Escherichia coli of a chemically synthesized gene for [Leu-28]echistatin. Gene (1989) 0.81
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 9.92
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell (1998) 5.60
Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A (1981) 5.10
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J (2001) 4.61
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 4.43
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry (1995) 4.10
Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell (1983) 3.93
Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem Sci (1996) 3.72
Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med (1999) 3.64
Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J Virol (1988) 3.49
The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol (1994) 3.48
Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA. J Virol (1977) 3.38
Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J (1999) 3.35
Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell (1979) 3.35
Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. J Virol (1983) 3.30
Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci U S A (1988) 3.29
Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A (1979) 3.10
Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end. Proc Natl Acad Sci U S A (1986) 3.09
Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol (1999) 3.04
9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci U S A (1983) 3.03
Adaptation of retinal processing to image contrast and spatial scale. Nature (1997) 2.92
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol (2001) 2.83
Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep (2000) 2.74
Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol (1975) 2.72
Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol (1981) 2.68
The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev (1994) 2.64
Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A (1980) 2.56
High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill (2010) 2.56
Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol (1994) 2.54
Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease. J Virol (1983) 2.53
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci U S A (1995) 2.49
Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem (2001) 2.47
Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol (1997) 2.41
Gene structure of human cardiac hormone precursor, pronatriodilatin. Nature (1985) 2.41
Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology (1973) 2.40
Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol (1985) 2.38
The neural code of the retina. Neuron (1999) 2.35
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci U S A (1990) 2.32
Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol (1999) 2.26
Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures. J Virol (1976) 2.22
Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol (1987) 2.21
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci U S A (1997) 2.20
The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J Virol (1987) 2.20
Influenza viral RNPs newly synthesized during the latent period of viral growth in MDCK cells. Virology (1971) 2.19
Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts. J Virol (1975) 2.17
A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol (1997) 2.16
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob Agents Chemother (1994) 2.13
The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA (1995) 2.12
In silico identification of novel selenoproteins in the Drosophila melanogaster genome. EMBO Rep (2001) 2.12
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. Antimicrob Agents Chemother (1993) 2.10
Two distinct SECIS structures capable of directing selenocysteine incorporation in eukaryotes. RNA (1999) 2.06
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors. J Biol Chem (1992) 2.04
Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol (1997) 2.01
Influenza viral messenger RNA. Virology (1974) 1.99
Segments of influenza virus complementary RNA synthesized in vitro. J Virol (1978) 1.97
Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Mol Cell Biol (1984) 1.97
Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood (1999) 1.97
Cloning and functional characterization of human selenophosphate synthetase, an essential component of selenoprotein synthesis. J Biol Chem (1995) 1.96
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun (1998) 1.95
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A (1998) 1.94
Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells. Virology (1972) 1.92
IFNs activate toll-like receptor gene expression in viral infections. Genes Immun (2001) 1.90
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Ann Intern Med (2000) 1.88
Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science (1998) 1.85
Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein. Vaccine (1999) 1.83
Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol (1995) 1.82
Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol (1988) 1.77
The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology (1995) 1.74
Priming and inhibitory activities of RNAs for the influenza viral transcriptase do not require base pairing with the virion template RNA. Proc Natl Acad Sci U S A (1980) 1.72
SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy. EMBO J (2000) 1.72
Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol (1998) 1.71
Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J Immunol (1997) 1.69
Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J Biol Chem (2001) 1.68
Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNA. Mol Cell Biol (2001) 1.66
Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol (1995) 1.61
Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol (1986) 1.61
The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology (1996) 1.60
Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus. J Virol (1986) 1.59
Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev (1992) 1.59
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. JAMA (1998) 1.59
Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell (1984) 1.57
The Caenorhabditis elegans homologue of thioredoxin reductase contains a selenocysteine insertion sequence (SECIS) element that differs from mammalian SECIS elements but directs selenocysteine incorporation. J Biol Chem (1999) 1.56
The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun (1984) 1.56
Identification of the RNA region transferred from a representative primer, beta-globin mRNA, to influenza mRNA during in vitro transcription. Nucleic Acids Res (1980) 1.55
Nuclear accumulation of influenza viral RNA transcripts and the effects of cycloheximide, actinomycin D, and alpha-amanitin. J Virol (1979) 1.54
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J Med Chem (1993) 1.54
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. Antimicrob Agents Chemother (1994) 1.53
Impaired antiviral response in human hepatoma cells. Virology (1999) 1.52
IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur J Immunol (2001) 1.51
The segments of influenza viral mRNA. J Virol (1977) 1.51